- call +1-201-465-4211
- email sales@mrinsights.biz
Neurovascular embolectomy device is used during an embolectomy procedure. These devices are used for removal of emboli, obstructing the blood circulation, surgically. Usually, embolectomy is the least preferred option for treatment and other involved therapeutic options are anticoagulation and thrombolysis. Neurovascular device market has undergone a demand-shift with respect to products and techniques. Doctors want to adopt instruments and techniques that offer higher window for stroke treatment with high success rate and minimal post-surgical impact. This is supported by the fact that demand for bare platinum coils is growing at a higher pace in comparison to coated coils. This is mainly due to high costs of coated coils and their less improved clinical outcomes compared to bare platinum coils. Additionally, stroke treatment involves high healthcare expenditure that drives the focus on development of economical treatment techniques.
According to this study, over the next five years the Neurovascular Embolectomy Device market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Neurovascular Embolectomy Device business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Neurovascular Embolectomy Device market by product type, application, key manufacturers and key regions and countries.
This study considers the Neurovascular Embolectomy Device value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Aspiration Systems
Stent Retreival Systems
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Medical Center
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Boston Scientific Corporation
Cook Medical
DePuy Synthes
Edwards Lifesciences Corporation
iVascular SLU
LeMaitre Vascular, Inc
Medtronic
Straub Medical AG
Teleflex Inc
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Neurovascular Embolectomy Device consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Neurovascular Embolectomy Device market by identifying its various subsegments.
Focuses on the key global Neurovascular Embolectomy Device manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Neurovascular Embolectomy Device with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Neurovascular Embolectomy Device submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
2019-2024 Global Neurovascular Embolectomy Device Consumption Market Report
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Neurovascular Embolectomy Device Consumption 2014-2024
2.1.2 Neurovascular Embolectomy Device Consumption CAGR by Region
2.2 Neurovascular Embolectomy Device Segment by Type
2.2.1 Aspiration Systems
2.2.2 Stent Retreival Systems
2.3 Neurovascular Embolectomy Device Consumption by Type
2.3.1 Global Neurovascular Embolectomy Device Consumption Market Share by Type (2014-2019)
2.3.2 Global Neurovascular Embolectomy Device Revenue and Market Share by Type (2014-2019)
2.3.3 Global Neurovascular Embolectomy Device Sale Price by Type (2014-2019)
2.4 Neurovascular Embolectomy Device Segment by Application
2.4.1 Hospital
2.4.2 Medical Center
2.4.3 Other
2.5 Neurovascular Embolectomy Device Consumption by Application
2.5.1 Global Neurovascular Embolectomy Device Consumption Market Share by Application (2014-2019)
2.5.2 Global Neurovascular Embolectomy Device Value and Market Share by Application (2014-2019)
2.5.3 Global Neurovascular Embolectomy Device Sale Price by Application (2014-2019)
3 Global Neurovascular Embolectomy Device by Manufacturers
3.1 Global Neurovascular Embolectomy Device Sales Market Share by Manufacturers
3.1.1 Global Neurovascular Embolectomy Device Sales by Manufacturers (2017-2019)
3.1.2 Global Neurovascular Embolectomy Device Sales Market Share by Manufacturers (2017-2019)
3.2 Global Neurovascular Embolectomy Device Revenue Market Share by Manufacturers
3.2.1 Global Neurovascular Embolectomy Device Revenue by Manufacturers (2017-2019)
3.2.2 Global Neurovascular Embolectomy Device Revenue Market Share by Manufacturers (2017-2019)
3.3 Global Neurovascular Embolectomy Device Sale Price by Manufacturers
3.4 Global Neurovascular Embolectomy Device Manufacturing Base Distribution, Sales Area, Product Types by Manufacturers
3.4.1 Global Neurovascular Embolectomy Device Manufacturing Base Distribution and Sales Area by Manufacturers
3.4.2 Players Neurovascular Embolectomy Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Neurovascular Embolectomy Device by Regions
4.1 Neurovascular Embolectomy Device by Regions
4.1.1 Global Neurovascular Embolectomy Device Consumption by Regions
4.1.2 Global Neurovascular Embolectomy Device Value by Regions
4.2 Americas Neurovascular Embolectomy Device Consumption Growth
4.3 APAC Neurovascular Embolectomy Device Consumption Growth
4.4 Europe Neurovascular Embolectomy Device Consumption Growth
4.5 Middle East & Africa Neurovascular Embolectomy Device Consumption Growth
5 Americas
5.1 Americas Neurovascular Embolectomy Device Consumption by Countries
5.1.1 Americas Neurovascular Embolectomy Device Consumption by Countries (2014-2019)
5.1.2 Americas Neurovascular Embolectomy Device Value by Countries (2014-2019)
5.2 Americas Neurovascular Embolectomy Device Consumption by Type
5.3 Americas Neurovascular Embolectomy Device Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Neurovascular Embolectomy Device Consumption by Countries
6.1.1 APAC Neurovascular Embolectomy Device Consumption by Countries (2014-2019)
6.1.2 APAC Neurovascular Embolectomy Device Value by Countries (2014-2019)
6.2 APAC Neurovascular Embolectomy Device Consumption by Type
6.3 APAC Neurovascular Embolectomy Device Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Neurovascular Embolectomy Device by Countries
7.1.1 Europe Neurovascular Embolectomy Device Consumption by Countries (2014-2019)
7.1.2 Europe Neurovascular Embolectomy Device Value by Countries (2014-2019)
7.2 Europe Neurovascular Embolectomy Device Consumption by Type
7.3 Europe Neurovascular Embolectomy Device Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Neurovascular Embolectomy Device by Countries
8.1.1 Middle East & Africa Neurovascular Embolectomy Device Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Neurovascular Embolectomy Device Value by Countries (2014-2019)
8.2 Middle East & Africa Neurovascular Embolectomy Device Consumption by Type
8.3 Middle East & Africa Neurovascular Embolectomy Device Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Neurovascular Embolectomy Device Distributors
10.3 Neurovascular Embolectomy Device Customer
11 Global Neurovascular Embolectomy Device Market Forecast
11.1 Global Neurovascular Embolectomy Device Consumption Forecast (2019-2024)
11.2 Global Neurovascular Embolectomy Device Forecast by Regions
11.2.1 Global Neurovascular Embolectomy Device Forecast by Regions (2019-2024)
11.2.2 Global Neurovascular Embolectomy Device Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Neurovascular Embolectomy Device Forecast by Type
11.8 Global Neurovascular Embolectomy Device Forecast by Application
12 Key Players Analysis
12.1 Boston Scientific Corporation
12.1.1 Company Details
12.1.2 Neurovascular Embolectomy Device Product Offered
12.1.3 Boston Scientific Corporation Neurovascular Embolectomy Device Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Boston Scientific Corporation News
12.2 Cook Medical
12.2.1 Company Details
12.2.2 Neurovascular Embolectomy Device Product Offered
12.2.3 Cook Medical Neurovascular Embolectomy Device Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Cook Medical News
12.3 DePuy Synthes
12.3.1 Company Details
12.3.2 Neurovascular Embolectomy Device Product Offered
12.3.3 DePuy Synthes Neurovascular Embolectomy Device Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 DePuy Synthes News
12.4 Edwards Lifesciences Corporation
12.4.1 Company Details
12.4.2 Neurovascular Embolectomy Device Product Offered
12.4.3 Edwards Lifesciences Corporation Neurovascular Embolectomy Device Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Edwards Lifesciences Corporation News
12.5 iVascular SLU
12.5.1 Company Details
12.5.2 Neurovascular Embolectomy Device Product Offered
12.5.3 iVascular SLU Neurovascular Embolectomy Device Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 iVascular SLU News
12.6 LeMaitre Vascular, Inc
12.6.1 Company Details
12.6.2 Neurovascular Embolectomy Device Product Offered
12.6.3 LeMaitre Vascular, Inc Neurovascular Embolectomy Device Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 LeMaitre Vascular, Inc News
12.7 Medtronic
12.7.1 Company Details
12.7.2 Neurovascular Embolectomy Device Product Offered
12.7.3 Medtronic Neurovascular Embolectomy Device Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 Medtronic News
12.8 Straub Medical AG
12.8.1 Company Details
12.8.2 Neurovascular Embolectomy Device Product Offered
12.8.3 Straub Medical AG Neurovascular Embolectomy Device Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 Straub Medical AG News
12.9 Teleflex Inc
12.9.1 Company Details
12.9.2 Neurovascular Embolectomy Device Product Offered
12.9.3 Teleflex Inc Neurovascular Embolectomy Device Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 Teleflex Inc News
13 Research Findings and Conclusion
List of Tables and Figures
Figure Picture of Neurovascular Embolectomy Device
Table Product Specifications of Neurovascular Embolectomy Device
Figure Neurovascular Embolectomy Device Repo
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
